Literature DB >> 10754123

Lambert-eaton myasthenic syndrome in association with transitional cell carcinoma: a previously unrecognized association.

D R Collins1, S Connolly, M Burns, L Offiah, R Grainger, J B Walsh.   

Abstract

The Lambert-Eaton myasthenic syndrome is known to occur with, or precede, a variety of malignancies, most commonly oat cell carcinoma of the lung. We report the first case of this syndrome associated with transitional cell carcinoma of the bladder and ureter. A brief review of published reports on the presentation, diagnosis, and treatment is included.

Entities:  

Mesh:

Year:  1999        PMID: 10754123     DOI: 10.1016/s0090-4295(98)00583-4

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  3 in total

Review 1.  Lambert-Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer.

Authors:  Benedikt Schoser; Bruno Eymard; Joe Datt; Renato Mantegazza
Journal:  J Neurol       Date:  2017-06-12       Impact factor: 4.849

2.  Autonomic dysfunction in Lambert-Eaton myasthenic syndrome.

Authors:  S A Waterman
Journal:  Clin Auton Res       Date:  2001-06       Impact factor: 4.435

3.  Paraneoplastic production of heparin-like anticoagulant in a patient with metastatic transitional cell carcinoma.

Authors:  Kelly N Fahl; Stephen A Poon; Ketan K Badani; Mitchell C Benson
Journal:  Can Urol Assoc J       Date:  2009-10       Impact factor: 1.862

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.